Announcing the Launch of Journal of Scleroderma and Related Disorders
The
Journal of Scleroderma and Related Disorders (JSRD) is an international,
multi-disciplinary, peer-reviewed journal, targeting scientists and clinicians
interested in scleroderma and other related autoimmune and fibrotic diseases.
JSRD is the official journal of the European Scleroderma Trials and Research
group (EUSTAR) and the World Scleroderma Foundation, which supports scleroderma
research in all its aspects and is committed to improving the quality of life
for scleroderma patients and their families.
This
journal is the first and only peer-reviewed publication to focus entirely on scleroderma and
related disorders and publishes high quality, original research articles on the
epidemiology, natural history, pathophysiology, diagnosis, treatment and
outcome of these diseases, as well as reviews and thought-provoking editorials
and commentaries. JSRD aims to become the leading reference journal in the
field of scleroderma and related disorders worldwide.
Launched in February 2016 to coincide with the 4th Systemic Sclerosis World Congress held in
Lisbon, JSRD publishes three issues per year and additional supplements. The
standards of the Journal are set high by a distinguished, international
editorial board whose expertise span scleroderma, systemic sclerosis, and other
related diseases. Professors Marco Matucci-Cerinic and Masataka Kuwana were
appointed as the first Editors-in-Chief and have embarked on this compelling
endeavour with great enthusiasm. The first volume has seen a number of first
class articles, as well as publishing the abstracts from the Lisbon meeting.
The project of JSRD is ambitious and challenging for the
whole community of clinicians and researchers who are devoted to the
understanding of the disease. However, the Editorial Board are excited to
embark on this compelling endeavor, and are confident that JSRD will soon be an
important journal and communication platform for the entire community of scleroderma
and related conditions.
For more information please contact: Samantha Taylor, Wichtig International Limited, samantha.taylor@wichtig.com
|